Biocon files IPO prospectus for R&D arm Syngene
Biotech firm Biocon Ltd has filed a prospectus for the initial public offering of its USD 600 million research and development arm, Syngene, it said on Thursday.
Apr 23, 2015, 10:07 AM IST
Biocon to file for Syngene unit's IPO in two months: Sources
Biotechnology firm Biocon Ltd could file a prospectus for a share listing for its research services business arm Syngene International within the next two months, two sources directly involved in the process said.
Mar 31, 2015, 17:54 PM IST